Purpose

Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.

Condition

Eligibility

Eligible Ages
Between 1 Week and 100 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Individuals with Hirschsprung disease and their first degree relatives (any segment length of disease, with or without other congenital anomalies or health problems, single or multiple affected individuals in family)

Exclusion Criteria

  • Unable or unwilling to provide sample for genetic studies - Individual, parent, or guardian unable to comprehend and provide informed consent

Study Design

Phase
Study Type
Observational
Observational Model
Family-Based
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Families with Hirschsprung Disease Individuals with Hirschsprung disease and their affected and unaffected relatives.
  • Other: Identification of genetic causes of Hirschsprung Disease
    Blood, saliva, or DNA samples are requested from all study participants. The blood or saliva samples are used to isolate DNA in all participants. Blood samples are also used to establish cell lines in some participants.

Recruiting Locations

New York University School of Medicine
New York 5128581, New York 5128638 10016
Contact:
Monica Erazo, MS
212-263-8069
Monica.Erazo@nyulangone.org

More Details

Status
Recruiting
Sponsor
NYU Langone Health

Study Contact

Jenna Pucel, MS, CGC
212-263-8069
jenna.pucel@nyulangone.org

Detailed Description

Hirschsprung disease (HSCR) is a birth defect resulting from the absence of nerve (ganglion) cells in the gastrointestinal tract. Hirschsprung disease has a population incidence of 1/5000 live births and most often occurs as an isolated condition. However, approximately 30% of HSCR cases are associated with other birth defects such as Down syndrome, deafness, hypopigmentation, and congenital central hypoventilation syndrome. Hirschsprung disease is a genetic condition with autosomal dominant, autosomal recessive, and multigenic patterns of inheritance described. Dr. Aravinda Chakravarti's laboratory has been investigating the genetics of Hirschsprung disease (HSCR) for more than twenty five years. The goal of this research study is to identify genes harboring causative HSCR mutations and to better understand the complex inheritance of HSCR in families by whole genome mapping and sequencing studies. Specifically, the study aims to determine the frequency with which mutations in any human gene lead to familial and isolated forms of HSCR. Further, the study will collect clinical information and investigate possible genotype - phenotype correlations. Molecular analysis using markers and sequencing, and statistical analysis of these data will be used to identify regions of human chromosomes where putative HSCR disease genes may be located. In addition, the DNA sequence of known and/or suspected HSCR genes will be assessed in individual patients and their family members, in search of causative HSCR susceptibility variants and variants that may affect presentation of the disease and treatment outcomes. Phenotypic information will include pathology, surgical, and other clinical outcomes related to Hirschsprung disease. This study will hopefully lead to a better understanding of the genetics of HSCR and, further down the road, improved diagnosis, treatment, and genetic counseling. This study asks volunteers to: 1. Complete a medical/family history questionnaire 2. Provide access to some medical records 3. Submit blood samples from the individual(s) affected with Hirschsprung disease and his/her parents (if available)

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.